FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588897260> ?p ?o ?g. }

• W2588897260 endingPage "2140" @default.
• W2588897260 startingPage "2133" @default.
• W2588897260 abstract "Gastric cancer is a common gastrointestinal malignancy that accounts for a notable proportion of cancer‑associated mortalities worldwide. Cytoplasmic fragile X mental retardation 1‑interacting protein 2 (CYFIP2) is a novel p53‑mediated pro‑apoptotic protein whose expression is decreased in gastric cancer. However, whether decreased expression of CYFIP2 contributes to gastric carcinogenesis remains unclear. In order to mimic in vivo gastric tumor CYFIP2 expression levels, the present study used short hairpin RNA targeting CYFIP2 mRNA to silence CYFIP2 expression in MGC803 and SGC7901 gastric cancer cells. Gastric cancer cells with constitutively decreased CYFIP2 expression levels were successfully established. It was observed that CYFIP2 knockdown promoted proliferation and colony formation, and inhibited apoptosis in these cells. Furthermore, 5‑fluorouracil (5‑FU)‑induced apoptosis was decreased following inhibition of CYFIP2 expression. In SGC7901 cells, protein expression of active caspase‑3 and cleaved poly (ADP‑ribose) polymerase was increased following treatment with 5‑FU, while phosphorylated Akt serine/threonine kinase 1 (Akt) levels were decreased. These 5‑FU‑induced effects were reduced following CYFIP2 knockdown. In addition, inhibition of the Akt signaling pathway using the Akt inhibitor LY294002 restored CYFIP2‑knockdown SGC7901 cell chemosensitivity to 5‑FU. The results of the present study demonstrate that decreased CYFIP2 expression is associated with increased gastric tumor growth in vitro and that CYFIP2 knockdown‑induced activation of the Akt pro‑survival signaling pathway confers resistance to 5‑FU‑based chemotherapy in gastric cancer cells. Therefore, combined treatment with an Akt inhibitor and chemotherapeutic drugs may improve the efficacy of gastric cancer therapy in patients with low CYFIP2 expression." @default.
• W2588897260 created "2017-02-24" @default.
• W2588897260 creator A5000512963 @default.
• W2588897260 creator A5008612688 @default.
• W2588897260 creator A5036142816 @default.
• W2588897260 creator A5054844092 @default.
• W2588897260 creator A5058554865 @default.
• W2588897260 date "2017-02-14" @default.
• W2588897260 modified "2023-10-02" @default.
• W2588897260 title "Inhibition of CYFIP2 promotes gastric cancer cell proliferation and chemoresistance to 5-fluorouracil through activation of the Akt signaling pathway" @default.
• W2588897260 cites W1552266425 @default.
• W2588897260 cites W1804602290 @default.
• W2588897260 cites W1974746079 @default.
• W2588897260 cites W1991260236 @default.
• W2588897260 cites W1992710524 @default.
• W2588897260 cites W2000256035 @default.
• W2588897260 cites W2006259603 @default.
• W2588897260 cites W2013875083 @default.
• W2588897260 cites W2024884555 @default.
• W2588897260 cites W2025242143 @default.
• W2588897260 cites W2030813056 @default.
• W2588897260 cites W2034269086 @default.
• W2588897260 cites W2037881883 @default.
• W2588897260 cites W2040936222 @default.
• W2588897260 cites W2048108096 @default.
• W2588897260 cites W2055671617 @default.
• W2588897260 cites W2061161574 @default.
• W2588897260 cites W2078511129 @default.
• W2588897260 cites W2081613128 @default.
• W2588897260 cites W2105654981 @default.
• W2588897260 cites W2107277218 @default.
• W2588897260 cites W2129242642 @default.
• W2588897260 cites W2145360451 @default.
• W2588897260 cites W2146099158 @default.
• W2588897260 cites W2151816252 @default.
• W2588897260 cites W2153424791 @default.
• W2588897260 cites W2192080449 @default.
• W2588897260 cites W2279731086 @default.
• W2588897260 cites W2281081761 @default.
• W2588897260 cites W42260840 @default.
• W2588897260 cites W4236377851 @default.
• W2588897260 cites W4240352187 @default.
• W2588897260 cites W4243930828 @default.
• W2588897260 doi "https://doi.org/10.3892/ol.2017.5743" @default.
• W2588897260 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5403719" @default.
• W2588897260 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28454373" @default.
• W2588897260 hasPublicationYear "2017" @default.
• W2588897260 type Work @default.
• W2588897260 sameAs 2588897260 @default.
• W2588897260 citedByCount "13" @default.
• W2588897260 countsByYear W25888972602017 @default.
• W2588897260 countsByYear W25888972602019 @default.
• W2588897260 countsByYear W25888972602020 @default.
• W2588897260 countsByYear W25888972602021 @default.
• W2588897260 countsByYear W25888972602022 @default.
• W2588897260 countsByYear W25888972602023 @default.
• W2588897260 crossrefType "journal-article" @default.
• W2588897260 hasAuthorship W2588897260A5000512963 @default.
• W2588897260 hasAuthorship W2588897260A5008612688 @default.
• W2588897260 hasAuthorship W2588897260A5036142816 @default.
• W2588897260 hasAuthorship W2588897260A5054844092 @default.
• W2588897260 hasAuthorship W2588897260A5058554865 @default.
• W2588897260 hasBestOaLocation W25888972601 @default.
• W2588897260 hasConcept C121608353 @default.
• W2588897260 hasConcept C126322002 @default.
• W2588897260 hasConcept C173396325 @default.
• W2588897260 hasConcept C185592680 @default.
• W2588897260 hasConcept C190232843 @default.
• W2588897260 hasConcept C190283241 @default.
• W2588897260 hasConcept C2781018059 @default.
• W2588897260 hasConcept C29537977 @default.
• W2588897260 hasConcept C502942594 @default.
• W2588897260 hasConcept C55493867 @default.
• W2588897260 hasConcept C555283112 @default.
• W2588897260 hasConcept C62112901 @default.
• W2588897260 hasConcept C62478195 @default.
• W2588897260 hasConcept C71924100 @default.
• W2588897260 hasConcept C75217442 @default.
• W2588897260 hasConcept C86803240 @default.
• W2588897260 hasConcept C95444343 @default.
• W2588897260 hasConcept C96232424 @default.
• W2588897260 hasConceptScore W2588897260C121608353 @default.
• W2588897260 hasConceptScore W2588897260C126322002 @default.
• W2588897260 hasConceptScore W2588897260C173396325 @default.
• W2588897260 hasConceptScore W2588897260C185592680 @default.
• W2588897260 hasConceptScore W2588897260C190232843 @default.
• W2588897260 hasConceptScore W2588897260C190283241 @default.
• W2588897260 hasConceptScore W2588897260C2781018059 @default.
• W2588897260 hasConceptScore W2588897260C29537977 @default.
• W2588897260 hasConceptScore W2588897260C502942594 @default.
• W2588897260 hasConceptScore W2588897260C55493867 @default.
• W2588897260 hasConceptScore W2588897260C555283112 @default.
• W2588897260 hasConceptScore W2588897260C62112901 @default.
• W2588897260 hasConceptScore W2588897260C62478195 @default.
• W2588897260 hasConceptScore W2588897260C71924100 @default.
• W2588897260 hasConceptScore W2588897260C75217442 @default.
• W2588897260 hasConceptScore W2588897260C86803240 @default.
• W2588897260 hasConceptScore W2588897260C95444343 @default.

• next